Embryonic exposures of lithium and homocysteine and folate protection affect lipid metabolism during mouse cardiogenesis and placentation  by Han, Mingda et al.
E
p
p
M
K
a
b
a
A
R
R
A
A
K
M
H
P
G
H
L
F
F
1
i
m
p
e
g
t
o
p
o
e
d
P
h
0
0Reproductive Toxicology 61 (2016) 82–96
Contents lists available at ScienceDirect
Reproductive  Toxicology
j ourna l ho me pa g e: www.elsev ier .com/ locate / reprotox
mbryonic  exposures  of  lithium  and  homocysteine  and  folate
rotection  affect  lipid  metabolism  during  mouse  cardiogenesis  and
lacentation
ingda  Hana,1, Alexei  V.  Evsikovb,1,  Lifeng  Zhanga,2,  Rosana  Lastra-Vicentea,
ersti  K.  Linaska,∗
Dept. of Pediatrics, USF Morsani College of Medicine, USF Children’s Research Institute, St. Petersburg, FL33701, United States
Dept of Molecular Medicine, USF Morsani College of Medicine, Tampa, FL, United States
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 22 April 2015
eceived in revised form 10 March 2016
ccepted 11 March 2016
vailable online 15 March 2016
eywords:
ouse embryo
a  b  s  t  r  a  c  t
Embryonic  exposures  can increase  the  risk  of congenital  cardiac  birth defects  and  adult  disease.  The
present  study  identiﬁes  the  predominant  pathways  modulated  by  an acute  embryonic  mouse  exposure
during  gastrulation  to  lithium  or homocysteine  that induces  cardiac  defects.  High  dose  periconceptional
folate  supplementation  normalized  development.  Microarray  bioinformatic  analysis  of  gene  expression
demonstrated  that primarily  lipid metabolism  is  altered  after  the  acute  exposures.  The  lipid-related
modulation  demonstrated  a gender  bias  with  male  embryos  showing  greater  number  of lipid-related
Gene  Ontology  biological  processes  altered  than in  female  embryos.  RT-PCR  analysis  demonstrated  sig-eart
lacenta
ender
omocysteine
ithium
olic acid
niﬁcant  change  of  the  fatty  acid  oxidation  gene  Acadm  with  homocysteine  exposure  primarily  in  male
embryos  than  in  female.  The  perturbations  resulting  from  the  exposures  resulted  in growth-restricted
placentas  with  disorganized  cellular  lipid  droplet  distribution  indicating  lipids  have  a critical  role  in
cardiac-placental  abnormal  development.  High  folate  supplementation  protected  normal  heart-placental
function,  gene  expression  and  lipid  localization.
© 2016  The  Authors.  Published  by  Elsevier  Inc.  This  is an  open  access  article  under  the  CC  BY-NC-ND
atty acid oxidation
. Introduction
Although the vertebrate mammalian embryo is well protected
n the uterus, many factors, such as drugs and maternal nutritional
etabolites can cross the placenta and interfere with regulatory
athways directing both placental and embryonic development
arly in gestation leading to congenital anomalies and intrauterine
rowth restriction. Differentiating cells are especially vulnerable
o exposures. In the case of cardiomyocyte speciﬁcation, it is one
f the earliest cell-fate decisions to occur in the embryo, taking
lace during gastrulation. During this same developmental period
f cardiogenesis, yolk sac and placental development is ongoing
xtra-embryonically to facilitate the exchange of nutrients and
Abbreviations: HCy, homocysteine; Li, lithium; FA, folic acid; LD, lipid droplets.
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gases between the mother and the soon functioning embryonic
cardiovascular system.
That congenital heart defects (CHDs) are one of the most preva-
lent types of human birth defects [1], most likely relates to the
cardiovascular system being the ﬁrst organ-system in the embryo
to develop followed closely by neurogenesis. The bilateral heart
ﬁelds are speciﬁed during gastrulation, a developmental period
in which we can induce a high incidence of CHDs in the avian
and mouse models by exposing embryos acutely to factors altering
the in utero milieu [2–4]. Extrapolating our mouse data to human
pregnancy, the exposures occur between the 2nd and 3rd week of
human gestation post-conception. Between the second and third
week of human gestation, common cell signaling pathways have
been activated for cardiomyocyte and trophoblast cell speciﬁca-
tion and differentiation leading to heart development and placenta
formation, respectively. The statistic that 49% of all human preg-
nancies are unplanned [5], indicates the ﬁrst month of gestation is
a high-risk period for the early embryo because the mother may not
yet be taking precautionary methods to protect embryonic devel-
opment. Thus, early embryogenesis is highly at risk for adverse
effects of drugs, alcohol, and other adverse exposures.
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Our acute exposure experiments targeting gastrulation on
mbryonic day (E) 6.75 of mouse gestation where morning of
onception is taken as E0.5, relates to our perturbing not only car-
iomyocyte speciﬁcation and differentiation, but also trophoblast
ifferentiation and thus subsequent placental development [6–8].
e published previously that Wnt/-catenin signaling important
n early cardiac and trophoblast cell differentiation is perturbed
y the early exposures. Several studies of mouse embryogenesis
etween E4.5 to E7 indicate that the trophectodermal cells over-
ying the inner cell mass (ICM) and the early extra-embryonic
ctoderm act as a pool of stem cells for the trophoblast lineages
nd respond to ICM signals, including to Wnt  signaling, for their
ifferentiation and proliferation [9,10]. That results of our mouse
tudy exposing trophoblasts may  relate to human trophoblasts
s well, is shown by a previously published study from my  lab-
ratory that demonstrated that exposure of incubated human
TR-8/SVneo extravillous trophoblasts to lithium (Li+), homocys-
eine (HCy), or alcohol (ethanol, EtOH) altered gene and protein
xpression and decreased human trophoblast cell migration [11].
n vivo acute exposure of the embryonic mouse to these three fac-
ors induced changes in the expression of similar proteins and genes
n the placentas of the same mouse embryos that displayed cardiac
nomalies and growth restriction [2,3].
In our present study described here we further analyzed the
ffects of the two factors Li+ and HCy in the induction of cardiac
irth defects and placental changes in the mouse model [3]. In
he human population it has been known that women  with muta-
ions in methylenetetrahydrofolate reductase (MTHFR) in the folic
cid cycle have higher than normal serum levels of HCy and are at a
igher risk than in the normal population to giving birth to babies
ith heart defects [12,13]. The metabolite HCy, a hallmark of folic
cid deﬁciency, appears to be a causative factor in the induction
f the defects [14]. Similarly, women who must be maintained on
i+ therapy during pregnancy are at a higher risk for giving birth to
abies born with cardiac defects [15]. During mouse gestation, pla-
ental abnormalities and similar cardiac, including valve, defects
nd changes in early cardiac gene expression occur by just a single
xposure during gastrulation on E6.75 to Li+ or to an elevated level
f HCy [2,3,11]. This was later shown also with acute alcohol (EtOH)
xposure [16]. We  also demonstrated that the adverse effects of the
cute exposures are prevented by dietary supplementation of folic
cid initiated periconceptionally and at a relatively high concen-
ration [3,16]. That seemingly disparate factors all induced similar
ardiac and placental abnormalities in the mouse model with the
ame timing of exposure and that could be prevented by folic
cid supplementation, suggested that some common cell processes
ere being perturbed that intersected with folic acid metabolism.
he present study was to deﬁne dominant common processes with
 focus on HCy and Li+ exposures.
Recent published data of human pregnancy indicate that a male
ssociation exists in relation to severity of congenital heart defects.
esults of two studies on the prevalence of congenital heart dis-
ase at live births, one study on 5190 newborns in Shanghai using
chocardiographic screening [17], and a second similar study in
ermany [18], indicated a male predominance in cases of severe
HDs (e.g., hypoplastic left heart syndrome; interruption of the
ortic arch, single ventricle, double outlet right ventricle, tetral-
gy of Fallot, among others). A female predominance was  observed
n cases of mild CHDs (e.g., small ventricular septal defect, mild
ulmonary stenosis). These data substantiate a large US popula-
ion study of sex differences in mortality in children undergoing
ongenital heart disease surgery where it was reported more male
hildren underwent CHD surgery and had higher-risk procedures
han female [19]. Mechanisms underlying these gender-based dif-
erences are not known. Severe CHD is associated with prematurity
nd low birth weight. The fetus is dependent on the placenta for aicology 61 (2016) 82–96 83
supply of long chain polyunsaturated fatty acids that are essential
in fetal growth and development and when the supply is compro-
mised, low birth weight can ensue. Thus, we decided to incorporate
analysis of the placenta and gender aspects into our study.
The objective of the present study using the mouse model was
to determine other dominant pathways besides Wnt  signaling that
are dysregulated by Li+ and HCy in cardiac and placental tissues and
that are maintained normally by folate supplementation. It is noted
that both Li+ and HCy exposures signiﬁcantly affected expression
of genes associated with Wnt  signaling. We  [2] and others [20,21]
have reported on that previously and did not address it here further.
To deﬁne other dominant pathways, we  chose to use a high-
throughput method, microarrays and bioinformatics analyses of
the data on exposed embryonic mouse hearts, with and without
high dose folic acid dietary supplementation. For analysis of the
microarray data from a relatively small sample size, we adapted an
approach used in cancer research focusing on Gene Ontology (GO)
categories [22] followed by Visual Annotation Display analysis [23]
to obtain lists of signiﬁcantly over-represented GO nodes that were
then analyzed for common biological processes altered by Li+, HCy
and maintained by folic acid. For such characterization and inter-
pretation of high throughput data, GO terms provide a controlled
and hierarchical manner of categorization [24]. GO is a categoriza-
tion of gene products characteristics, rather than a categorization
of the gene products themselves. Thus, a high number of gene prod-
ucts can be grouped on the basis of their characteristics as deﬁned
by the GO classiﬁcations and aid in deﬁning processes involved in
both normal development and in disease.
Using GO categorization presented here, we demonstrate that
alterations within processes associated with lipid metabolism were
chieﬂy altered and occurred differentially in male and female
embryos in response to the exposures in utero and that were
prevented by folic acid supplementation. We  then focused on
the lipid-related effects of the two  acute exposures administered
during early pregnancy. Validation of the bioinformatics analysis
in heart and placental tissues was  carried out using molecu-
lar, immuno- and histochemical techniques. We  suggest that our
results using the mouse model in part underlie the gender differ-
ential with severity of CHDs observed in the human population
[17–19].
2. Materials and methods
2.1. Animals
2.1.1. Inbred C57BL/6J mouse strain
The C57BL/6J mice were purchased from The Jackson Laborato-
ries, Inc., Bar Harbor, ME.  It has become recognized that mouse
strains can differ in their response to factors [25–27]. Thus, the
mouse strain being used should be taken into consideration when
comparing different studies.
2.1.2. Husbandry and breeding
The adult mice were housed at an ambient temperature of 22 ◦C
with a 12 h light/dark cycle and access to food and water ad libi-
tum. For timed matings, mature male and female mice were housed
overnight and the presence of a vaginal plug the following morning
was taken as evidence of mating and designated as embryonic day
0.5 (E0.5).
All protocols pertaining to handling of mice were approved by
the Institutional Animal Care and Use Committee (IACUC) of the
USF Morsani College of Medicine.2.1.3. Control folic acid and high folic acid diets
The mouse diets were specially ordered from Harlan Labora-
tories (Madison, WI). The control diet provides 3.3 mg/kg as the
8 ve Tox
b
i
v
m
d
i
t
7
a
o
b
u
s
m
2
r
1
m
i
b
t
E
(
d
t
t
t
u
i
i
a
[
f
n
2
o
a
a
c
i
i
2
i
a
T
l
e
s
t
i
T
a
e
v
D
t4 M. Han et al. / Reproducti
aseline folic acid concentration to maintain mouse health, but
s an amount that we previously demonstrated does not pre-
ent cardiac defects. The special “high” folic acid-supplemented
ouse diet contains 10.5 mg/kg folic acid and prevented the noted
efects. The high folic acid adjusted diet was designed to be sim-
lar in macronutrients, ﬁber and micronutrients (where feasible)
o the 2018 standard diet, but using reﬁned ingredients. Folic acid,
.2 mg/kg, was added to the base of 3.3 mg/kg in the baseline diet for
 total of 10.5 mg/kg. This level of folic acid represents a supplement
f 460 ng/g BW (body weight) taking into consideration metabolic
ody size [3]. This folic acid concentration we based on an amount
sed in human population clinical studies [28]. The detailed diet
peciﬁcations provided by Harlan are available in the Supplemental
aterials.
.1.4. Exposure to HCy or Li+
Treated pregnant mice on E6.75 were randomly allocated to
eceive intraperitoneally (i.p.) an injection of either a single dose of
00 l of 6.25 mg/ml  of lithium chloride (Li+), as previously deter-
ined [2], or 100 l of 75 M HCy [3]. Control mice received i.p.
njections of physiological saline (100 l of 0.9% NaCl). Based on our
reeding protocol and detection of the vaginal plug, an i.p. injec-
ion at 17:30 h on E6 was determined to be optimal for exposure at
6.75. All pregnant mice were placed on the morning of conception
E0.5) either on the baseline folic acid 3.3 mg/kg chow or the high
ietary folic acid chow of 10.5 mg/kg. All treatment groups and con-
rol animals were then maintained on the deﬁned diets throughout
he study. On E15.5, the heart and utero-placental circulation of
he embryos were examined noninvasively in utero using Doppler
ltrasonography (echo) [29]. As previously published, the Li+/HCy
.p. injections of dams on maintenance folic acid diet induced sim-
lar cardiac valve defects and altered myocardial and umbilical
rtery blood ﬂow as detected noninvasively by echocardiography
3,29]. E15.5 embryos with abnormal echo patterns [3] were chosen
or further analysis to compare with the control embryos displaying
ormal blood ﬂow.
.1.5. Euthanasia
Pregnant mice on E15.5 were euthanized by an excess amount
f CO2 with a ﬂow rate of 4 l/min. At cessation of cardiovascular
nd respiratory movements, females remained in the cage for an
dditional minute. Once the female was removed a cervical dislo-
ation was performed to conﬁrm euthanasia. Uterine horns were
mmediately removed and placed into a petri dish of cold PBS on
ce and the embryos were removed for the different assays.
.2. Doppler echocardiography
On E15.5 the pregnant mice were sedated using 3–4% Isoﬂurane
nhalation and the echocardiography (echo) was carried out using
 Vevo 770 or Vevo 2100 system (VisualSonics of SonoSite, Inc.,
oronto, Ontario, Canada) to determine which embryos within the
itter were displaying cardiac abnormalities. We  chose E15.5 for
cho analysis, as a four-chambered heart with functional valves
hould normally be present [29]. The embryos were visualized and
heir position mapped in each uterine horn. After the echo exam-
nation, all of the E15.5 embryos within the litter were isolated.
able 1 provides the percentages of mouse embryos with normal
nd abnormal ultrasound patterns and the numbers of resorbed
mbryos obtained with the acute exposures. Echo parameters pre-
iously published are provided in the Supplementary data section.
etailed analyses and discussion of the abnormal ultrasound pat-
erns can be found in our previous publications [3,30].icology 61 (2016) 82–96
2.3. Total RNA extraction and affymetrix microarray analysis
Six pregnant C57BL/6J mice were used for the microarray anal-
ysis. Control embryos and folic acid-protected embryos displaying
normal heart function and placental blood ﬂow and the Li+/HCy
exposed embryos displaying semilunar valve regurgitation and
abnormal blood ﬂow patterns were isolated. Two  different embryos
from the same dam’s litter served as duplicate samples for each
control and experimental treatment groups; therefore 6 different
groups (litters), i.e., 12 embryos were analyzed. Genotyping by RT-
PCR for gender of embryos was not done for microarray analysis.
Thus, a total of 12 embryonic E15.5 micro-dissected heart samples
were analyzed by microarrays for changes in gene expression, i.e.,
over a week after the acute exposures were administered on E6.75.
In summary, the treatment groups included embryos that received:
(1) high dietary folic acid (FA) only (10.5 mg/kg body weight), with
0.9% saline by i.p., and had normal echos; (2) Li+ in saline by i.p.,
injection, maintenance diet FA (3.3 mg/kg body weight), and had
abnormal echos; (3) Li+ in saline by i.p., injection, with high dietary
FA supplementation, normal echos; (4) HCy in saline by i.p., main-
tenance FA diet, abnormal echos; (5) HCy in saline by i.p., with
high dietary FA supplementation, normal echos; or (6) control 0.9%
saline by i.p., maintenance FA diet, with normal echos. Because
the outﬂow (OFT) and right ventricular (RV) regions were most
affected with our timing of acute exposure, these regions only were
microdissected together and total RNA was extracted. The left ven-
tricles were not used. Total RNA was extracted using the RNA Micro
Kit (Qiagen, Valencia, CA) and was sent to The Mofﬁtt Cancer Center
Microarray Facility that carried out the microarray hybridization.
The samples were processed in one batch.
Total RNA (100 ng) was  obtained per tissue sample. To overcome
tissue limitations, the WT-Ovation Pico RNA Ampliﬁcation System
(NuGEN Technologies, Inc., San Carlos, CA) was  used to prepare
sufﬁcient quantities of cDNA for microarray analysis. Ampliﬁca-
tion starts at the 3′ end as well as randomly throughout the whole
transcriptome in the sample, thus decreasing 3′ bias upon ampliﬁ-
cation. The ampliﬁed cDNA was  used as input for hybridization to
Affymetrix GeneChip Mouse Genome 430 2.0 arrays (Affymetrix,
Inc., Santa Clara, CA). Hybridization, staining, and scanning of the
chips was performed as outlined in the Affymetrix technical man-
ual. The mouse 430 2.0 arrays contain over 45,000 probe sets
designed from GenBank, dbEST, and RefSeq sequences clustered
based on build 107 of the UniGene database. The clusters were fur-
ther reﬁned by comparison to the publicly available draft assembly
of the mouse genome. An estimated 39,000 distinct transcripts are
detected including over 34,000 well-substantiated mouse genes.
Each gene is represented by a series of oligonucleotides that are
identical to sequence in the gene and oligonucleotides that con-
tain a homomeric (base transversion) mismatch at the central base
position of the oligomer used for measuring cross hybridization.
Scanned output ﬁles were visually inspected for hybridization
artifacts and then analyzed using Affymetrix GeneChip Operat-
ing Software (GCOS). Signal intensity was  scaled to an average
intensity of 500 prior to comparison analysis. Using the default set-
tings, GCOS software identiﬁes the increased and decreased genes
between any two  samples with a statistical algorithm that assesses
the behavior of 11 different oligonucleotide probes designed to
detect the same gene [31]. Probe sets that yielded a change p-
value less than 0.002 were identiﬁed as changed (increased or
decreased) and those that yielded a p-value between 0.002 and
0.002667 were identiﬁed as marginally changed. A gene was iden-
tiﬁed as consistently changed if it was identiﬁed as changed in all
replicate experiments by the software. Affymetrix CEL ﬁles were
analyzed using MAS5 algorithm [31,32] of Expression Console Suite
(Affymetrix).
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Table  1
Comparison of Percentages of Normal and Abnormal Embryos and Numbers of Resorptions.
Treatment Litter # Normal% Abnormal% Total Embryos # Resorption # Folate Conc
Controla 27 100 0 147 0 3.3 mg/kg
High  Folatea 9 100 0 58 0 10.5 mg/kg
Hcysb 23 53.7 46.3 119 41 3.3 mg/kg
Lib 21 39.8 60.2 108 21 3.3 mg/kg
HCys  + Folate 7 100 0 40 0 10.5 mg/kg
Li  + Folate 8 97.6 2.4 41 1 10.5 mg/kg
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b Pregnant animals receiving i.p., injections of the speciﬁed substance with main
.4. Bioinformatic analysis
As indicated above we had six treatment groups (n = 6), i.e., 6
regnant C57BL/6J mice, including the control groups. In each treat-
ent group we analyzed two embryos from each litter. At this point
f our study we were not addressing gender, but only dominant bio-
ogical processes being altered and genotyping had not been done.
ecause developing embryos have gender biases in gene expression
33], our initial quality control of the data and gender was  per-
ormed using expression values for X-inactivation transcript Xist
probesets 1427262 at, 1427263 at and 1436936 s at; present in
emales, absent in males) and Y-chromosome linked gene Ddx3y
1426438 at, 1426439 at and 1452077 at; present in males; absent
n females). According to these probesets, our microarray data of
mbryos that had been picked randomly and according to echo
nalysis of cardiac function, the embryos represented 6 male and 6
emale embryos:
Control 1 male 1 female
High Folate treatment 1 male 1 female
Li+ treatment 1 male 1 female
HCy treatment 1 male 1 female
Li+ + High Folate treatment 0 male 2 female
HCy + High Folate treatment 2 male 0 female
Because gender differences in gene expression between arrays
ontributed the largest variance among data, we devised a strategy
or data analysis with a low number of replicates. The strategy used
s adapted from analysis done in cancer research [22]. Many clinical
ata are being reanalyzed using this approach because of extreme
oise between individual patient samples. Focusing on GO terms
or pathways, or other types of gene function groupings) rather than
ndividual genes, clariﬁes the noise. Thus to increase the sampling
ower of our microarray data, we tested dysregulation of expres-
ion in the groups of genes identiﬁed by the Gene Ontology (GO)
ategories. For this, we performed pairwise analysis for all 12 sam-
les individually in which each probeset was assigned as “present”,
downregulated”, “upregulated” or “inconsistent” depending on
he ratio of the signals between samples, and consistency of these
atios among probesets representing the same gene. Next, non-
arametric analysis of these data was done using Visual Annotation
isplay (VLAD) that performs hypergeometric distribution of GO
nnotations for a given set of genes (i.e., up- or downregulated) vs.
universal set of genes (i.e., all genes ‘present’ in the samples) [23]. A
 value p < 0.001 was considered of statistical signiﬁcance. The out-
uts of each VLAD comparisons, which are the lists of signiﬁcantly
ver-represented GO nodes, were subsequently analyzed for com-
onality. After obtaining the common GO categories signiﬁcantly
ver-represented among the twelve embryos, we then sorted out
he common category list according to gender of the embryos. We
voided the use of False Discovery Rate (FDR) corrections such as
enjamini-Hochberg because these methods are not suitable for
DR estimation in GO enrichment [34]. Validation of the bioin-
ormatics results was then carried out using immuno-, including
istochemical, molecular, and cellular approaches described below.ions of physiological saline.
e diet.
The Affymetrix microarray CEL ﬁles are deposited into the Gene
Expression Omnibus (GEO), the public repository of microarray
data.
2.5. RT-PCR analysis of effects of exposure and diet on lipid gene
expression
The gene expression changes for Acadm,  Acadl, and Crt were
analyzed by RT-PCR of E15.5 total hearts or placental tissues, as
deﬁned. Data was  normalized in each case to the internal control
-actin. Relative quantitation is shown using densitometric read-
ings from scans of the gels. Average densitometric readings were
obtained. We  show standard deviations, but it is to be noted that
not all embryos within a litter in utero are at the same time-point
of development at time of exposure and embryos analyzed were
from different litters. Thus intra- and inter-litter variability led to
expected variations in quantitation. We  were primarily interested
in determining whether patterns of changes in the deﬁned bio-
logical processes can be observed. Our initial validation studies
did not address gender, but only lipid-related changes as based
on our microarray data of GO categories being modulated and
on publications from other studies [35]. After sorting the bioin-
formatics data according to gender, we later included gender in
the validation studies as related to Acadm gene described here.
For gender-associated gene modulation in the second part of the
study, we  analyzed placental tissue from four embryos of each
gender (speciﬁed by genotyping tissue from the posterior half of
each embryo) for the speciﬁc exposure group having the same type
of cardiac defects, speciﬁcally semilunar valve regurgitation and
abnormal myocardial function and umbilical artery blood ﬂow. The
embryos were from different litters.
The two lipid-related genes that we  chose to analyze were
based on genes that over-lapped in several of the yellow high-
lighted GO categories involving lipid metabolism: Speciﬁcally, the
two fatty acid oxidation genes acyl-CoA-dehydrogenases -long length
chain (Acadl) and –medium length chain (Acadm) overlapped in
multiple categories affected by Li+ and HCy, transgenic mice for
these genes had been generated, and those mice were reported
to have heart-related problems [36,37]. For comparison we  also
analyzed calreticulin (Crt), a gene that is not directly involved in
lipid metabolism and codes for a Ca + +-binding storage protein
and chaperone in the endoplasmic reticulum, important in main-
tenance of cellular calcium homeostasis, and has a role in embryo
implantation in mice [38]. Primer sequences are given in Supple-
mental Table I.
2.5.1. Statistics
ANOVA (analysis of variance) was used to test the null hypoth-esis and statistical signiﬁcance taking into account gender and the
various treatment groups. This was followed by the two-tailed t-
test to address statistical signiﬁcance for the speciﬁc gender in
comparison to control.
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.6. Embryo gender determination for lipid-related gene
xpression analysis
DNA was extracted from posterior halves of the E15.5 embryos
hat were chosen for sex determination according to published
CR-based methodology [39]. The reaction includes primer pairs
or Sry [40] on the Y chromosome and Myog (myogenin)  [39] that
enerate a male speciﬁc band of 380 bp and an internal control band
f 245 bp, respectively. Primer sequences are provided in Supple-
ental Table I.
.7. Oil Red O (ORO) staining for lipid droplet distribution
ORO, a fat-soluble dye, was used to detect neutral lipids (triglyc-
rides, diacylglycerols, and cholesterol esters) in cryosectioned
15.5 cardiac and placental tissues. A published staining methodol-
gy was followed that provides an estimate of tissue lipid content
nd localization [41]. Lipid droplets stain red and nuclei blue. Polar
ipids (phospholipids, sphingolipids and ceramides) are not stained
42]. Stereoscopic quantitation of lipid droplets after exposures
as not done because of disorganized placental development and
neven distribution of ORO in the labyrinth and maternal decidua
f experimentally exposed tissue. Analysis of lipid droplet organi-
ation within tissues was done in a blinded manner by coding of the
issue sections of the different treatments and was carried out inde-
endently by the investigators and compared. We  did not quantify
umbers of lipid droplets in the tissues, because not all embryos
ithin a litter in utero are at the same time-point of development
t time of exposure and embryos analyzed were from different lit-
ers. Thus intra- and inter-litter variability was expected to lead
o variations in quantitation. Also in the placental labyrinth layer
here was variability in the extent of regions devoid of droplets right
ext to regions with droplets and intermediate zones. Quantitation
ould not show this. We  thus chose to show representative sec-
ions of the pattern of ORO localization of the heart and placenta
ithout quantitation.
Only ORO images of heart sections were similarly enhanced in
arallel using “autolevels” subroutine using Photoshop software
Adobe Systems, Inc., San Jose, CA) to bring out red color of small
roplet staining relative to background and for easier observa-
ion of the organization of the staining patterns. Pattern of lipid
roplets in the placenta was more distinctly noticeable and Photo-
hop enhancement was not done.
.8. Immunohistochemistry and microscopy
Li+-, HCy-, and control, NaCl-exposed, embryos were ﬁxed in
% paraformaldehyde in PBS, parafﬁn embedded, and sectioned.
mbryos were obtained from at least three different litters that
ad undergone same exposures. Duplicate sections of the tissues
rom the different treatments (control, experimental exposure, and
igh folate dietary protected tissue) were placed on the same slide
nd immunostaining was carried out at the same time for compari-
on of signal. Sections were immunostained with MCAD antibodies
Sigma, St. Louis, MO)  for the protein product of Acadm gene expres-
ion. Primary antibody localization was visualized with horseradish
eroxidase or ﬂuorescent Cy-3 conjugated-secondary antibodies
Vector Laboratories, Inc., Burlingame, CA). At the end hematoxylin
ounterstain was used for general visualization of tissue. Localiza-
ion of protein expression was analyzed with a Nikon Optiphot II
hase microscope (Nikon Instruments, Inc., Melville, NY). Digitized
mages were obtained with a Nikon DS-L2 Camera unit.Quantiﬁcation of horseradish peroxidase (HRP) brown stain-
ng in the tissues that is shown in the ﬁgures was obtained
sing Deﬁniens Tissue Studio 4.0 software (Deﬁneins AG, Munich,
ermany). The score is based on the average number of pixels oficology 61 (2016) 82–96
brown HRP signal present in two sections of that speciﬁc region
and tissue, as compared to the total area of the delineated regions.
This is deﬁned as a percentage for each region analyzed. For the
heart for each treatment, we  quantiﬁed the right and left ven-
tricular myocardium, including the adjacent trabecular region, and
the interventricular septum (IVS). For the placenta we quantiﬁed
a region of the maternal decidua/syncytiotrophoblasts, as well as
a uniform region of the labyrinth. The sections were all immunos-
tained at the same time following the same protocol and timing for
staining, and using the same reagents.
3. Results
3.1. Bioinformatic analysis of microarray data
The common signiﬁcantly over-represented GO nodes from
Li and HCy exposures based on the six treatment groups or 12
embryos (Fig. 1A and B) related to cell processes associated with
lipid metabolism and fatty acid oxidation (Fig. 1A, orange high-
lighted categories). The following six genes involved in fatty acid
oxidation were commonly represented in many of the highlighted
categories: acyl CoA dehydrogenase 11 (Acad11), acyl CoA dehydro-
genase long chain (Acadl), acyl CoA dehydrogenase medium chain
(Acadm), acyl CoA dehydrogenase short chain (Acads), acyl CoA
dehydrogenase very long chain (Acadvl), and electron transferring
ﬂavoprotein dehydrogenase (Etfdh). All of the protein products of
these genes localize to the mitochondria. Our initial validation stud-
ies of effects on lipid metabolism focused on lipid droplet patterns
and their modulation with exposures and diet. At the time these
earlier studies were done we were not anticipating that gender
may  have a role. We  later addressed possible gender association
by re-analyzing Acadm expression in response to HCy and Li+ (see
Figs. 5–7), because recent literature indicated (i) that fetal gender is
associated with lipid metabolism and (ii) that gender is also asso-
ciated with severity of heart defects; (iii) Acadm protein product
(MCAD protein) deﬁciency is the most common inherited disor-
der of mitochondrial fatty acid -oxidation in humans; and (iv) the
Acadm gene was among the commonly represented genes in many
of the orange highlighted categories shown in Fig. 1A.
When we  analyzed the list of common GO categories in Fig. 1A
by comparing separately the two  groups that were represented
by only one gender, i.e., the lithium-exposed and folate-protected
group had only two female embryos and the homocysteine-
exposed and folate–protected group was made up of two male
embryos (shown in Fig. 1B), more perturbation was observed in the
male embryonic heart transcriptome than in the female and a high
number of these categories related to lipid metabolism. Overall in
Fig. 1A and B male embryos showed a higher number of signiﬁ-
cant changes in the expression of genes in lipid-related categories
than the female embryos. Convention of yellow cells signifying
up–regulation and blue signifying down-regulation was used here.
Comparing the last column in Fig. 1A of the female control
groups, fol f1 vs cont f1 (i.e., the high folic acid- supplemented
female embryo versus control maintenance diet female embryo)
and the last column of the male control group, fol m1 vs cont m1
(high folic acid- supplemented male embryo versus control main-
tenance diet male embryo), it is noteworthy that although the high
folic acid supplementation on its own  did show some modulation
of some lipid-related cellular processes, as for example ATP syn-
thesis and energy coupled proton transport, most categories were
not altered. In focusing on the orange-highlighted lipid-metabolism
categories, in this small sample size in both the high folic acid diet
versus maintenance diet control groups, mostly nonsigniﬁcant (NS)
differences were observed for both genders (last column for each
gender). This was  conﬁrmatory to our observations and ultrasound
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Fig. 1. Bioinformatic analysis generated lists of dominant changes in Gene Ontology (GO) Speciﬁc Biological Processes in embryonic hearts after exposure to Li+ or to HCy,
with  and without folic acid supplementation. Lists shows embryos sorted according to gender with a comparison of treated female embryos compared to control female
embryos  highlighted in red at top; comparison of male embryos in light blue on top right. Lipid-related GO categories (on left) are highlighted in orange. The convention used
here  was  highlighting cells in yellow for the up-regulated processes and blue for down. Fig. 1A. Bioinformatics analysis of microarray data on Li+- and HCy-exposed embryonic
hearts,  with and without high dose folic acid supplementation are contrasted with both genders for each speciﬁed category. Fig. 1B. List of overlapping GO categories with
folic  acid protection. In Fig. 1B folic acid protection with Li+ exposure group consisted only of female embryos (red); folic acid protection with HCy exposure group (light
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ere  noted. Abbreviations: f, female; m, male; vs versus; lith, lithium exposure; hc
cys  fol, homocysteine exposure with high folate supplementation; NS, changes no
ata that even though the high folic acid supplementation may
lter gene expression within some categories, these changes main-
ained normal embryonic development of the heart and its function,
s did the health maintenance diet with low folic acid levels. It is
nly with the HCy- and Li+-exposures that signiﬁcant differences
n lipid metabolism-related categories appeared and often were
ifferentially regulated by gender.
It is noted that although 8 mg/kg folic acid was reported to have
dverse embryonic effects in the mouse strain 129S1/SvlmJmice
43], we did not see adverse effects using 10.5 mg/kg folic acid
ith the C57BL/6J strain. We  did not address folic acid deﬁciency
irectly, as there have been a multitude of studies indicating that
ow or no dietary folic acid leads to poor embryonic, including heart,
evelopment.
.2. Analysis of ORO localization of neutral lipid droplet
istribution in the heart and placentaThe bioinformatics analysis of the microarray data indicated that
roteins involved in fatty acid -oxidation and lipid metabolism are
odulated with folic acid deﬁciency. We  next evaluated effects ofes overlapping with same categories as in Fig. 1A. Notable differences in response
mocysteine exposure; lith fol, lithium exposure with high folate supplementation;
iﬁcant.
the HCy/Li+ exposures on lipid metabolism by using Oil Red O (ORO)
staining for neutral lipid droplets. For packaging, cells convert lipids
into neutral lipids and deposit them into intracellular organelles
(termed lipid droplets or adiposomes). These droplets are impor-
tant in maintaining cell homeostasis. Their accumulation in cells
is linked in common pathologies seen with obesity and diabetes
[44]. Previous studies linked Mthfr deﬁciency and low dietary folic
acid in the transgenic Mthfr model also with fetal loss, intrauter-
ine growth restriction and placental abnormalities, as well as with
heart defects [45,46]. Because our exposed embryos displayed
abnormal heart physiology, were growth restricted with smaller
placentas, and displayed altered umbilical artery blood ﬂow, we
included analysis of the placentas. Thus, we  deﬁned whether neu-
tral lipid synthesis and distribution were altered in the fetal E15.5
four-chambered heart (Fig. 2) or in the same embryo’s placenta
(Fig. 3). In both tissues we  observed changes in neutral lipid local-
ization with more severe alterations occurring in placental tissue.3.2.1. ORO cardiac localization
Lithium we reported had more severe effects on heart function
than HCy [3]. This can be seen here also in that the Li+ −exposed
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Fig. 2. Oil Red O staining of neutral lipid droplet distribution (red droplets, see black arrows) in control cardiac trabeculae in left column (Fig. 2A) and in the right myocardial
wall  in right column (Fig. 2B), and after experimental conditions of lithium exposure (Li+, Fig. 2C and D, respectively); Li+ with high folate (FA) supplementation (Fig. 2E, F);
HCy  exposure (Fig. 2G and H, respectively) and HCy with high FA supplementation (Fig. 2I and J, respectively). These ORO images of heart sections were all similarly enhanced
in  parallel for lipid droplet staining using “autolevels” subroutine in Photoshop.
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Fig. 3. Oil Red O staining of neutral lipid droplet distribution in labyrinth layer (Laby) and maternal deciduas (mat dec) in control (Con) placentas (Fig. 3A–F); homocysteine
(HCy)  exposed (Fig. 3E and H); in lithium (Li+) exposed placentas (Fig. 3I–L); and folic acid (FA) protected placentas (Fig. 3M–P). Boxed in labyrinth regions in 3E and I are
shown  at higher magniﬁcation in F,G for HCy exposure and J,K for Li+. Magniﬁcation bars (A,B) = 250 m;  for other panels, bars = 100 m.
Fig. 4. Modulation of Acyl CoA Dehydrogenase Gene expression in Embryonic Heart using RT-PCR. Fig. 4A: Gels shown depict Acyl CoA Dehydrogenase Acadm and Acadl gene
expression in E15.5 cardiac tissue after HCy and Li+ acute exposures administered during gastrulation. Lower signal in each lane is the internal control -actin. Panels 4B–G
are the graphs of densitometric scan averages with standard deviations using three mouse embryos/exposure for Acadm and Acadl expression with HCys (4B and C) and
Li+ (4D and E) treatments. No statistically signiﬁcant changes were apparent when gender was not taken into account. Abbreviations: M,  marker lane; C, control tissue; Ex,
experimentally exposed tissue; FA high folic acid supplementation before exposure.
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Fig. 5. Gender-associated changes in MCAD protein expression in embryonic heart tissue on E15.5 after HCy and Li+ exposures were administered during gastrulation.
Arrows point to some regions of localization. Control male (Fig. 5A) and control female (Fig. 5D) hearts show similar localization. In general a higher level of expression
was  apparent in the right ventricular myocardium (RV) than left (LV) and in the adjacent region of trabeculation (arrow) and in the interventricular septum (IVS; arrow).
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taining in hearts (arrows), with a slightly enhanced elevation apparent primarily 
agniﬁcation bar = 500 m for all panels.
earts have thinner myocardial walls than HCy-exposed and lipid
eposition was affected by the exposure. In the heart, trabeculae
Fig. 2A) and the ventricular myocardium (Fig. 2B) displayed ORO-
tained lipid droplets (LDs), but generally at a detectably lower
evel than in the placental tissue. In the acute Li+-exposed heart
Fig. 2C,D) neutral lipids were decreased and returned to control
evels with folic acid supplementation (Fig. 2E,F). HCy acute expo-
ure did not alter ORO staining in the trabeculae (Fig. 2G). The ORO
taining was noticeably prevalent in the epicardial layer (Fig. 2H).
ietary high folic acid only slightly altered the exposure pattern of
ardiac neutral lipid deposition (Fig. 2I and J) with HCy exposure.
attern of ORO localization in the heart was observed to be similar
mong embryos from different litters of the treatment groups..2.2. ORO placental localization
After Li+ and HCy exposures, more signiﬁcant changes in neutral
ipid synthesis and organization were noted in the placenta thanontrast to the female (Fig. 5E; see graph in 5G). Li+ exposure showed little MCAD
ale hearts (cf. Fig. 5C and F; see graph in 5H). Inset in G shows delineated regions.
in the heart and were localized to the labyrinth and the maternal
decidua regions (Fig. 3A). The fetal side of the placenta did not show
lipid localization in the control tissue (Fig. 3B) or after exposures
(not shown). ORO localization in control tissue is at a high level
in the labyrinth layer and displays a characteristic organization
(Fig. 3C). The red ORO lipid droplets are organized in rows in cells
along the villi. In the maternal decidua there is a high localization in
the region close to the syncytiotrophoblasts (Sy Tro; 3A,D), but little
staining is seen in association with the syncytiotrophoblasts them-
selves. With HCy exposure a patch-like neutral LD localization was
evident in the labyrinth (compare Fig. 3E, E, and G). In HCy exposed
villi, lipid droplets remain more organized (Fig. 3F, G) when com-
pared with Li+-exposed (Fig. 3J, K). Little or no ORO localization,
however, was  evident in large areas of the HCy-exposed labyrinth
(Fig. 3F). A similar result of patch-like localization was observed
in the maternal decidua layers (Fig. 3H). With Li+ exposure, the
relatively uniform and organized localization within the labyrinth
ve Toxicology 61 (2016) 82–96 91
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Fig. 6. Relative quantitation of Acadm gene expression in placental tissue using
RT-PCR and taking into account gender: Results are shown for gene expression in
placental tissue for Acadm (Fig. 6A; n = 3 embryos from three different litters for each
treatment) and for Crt (Fig. 6B; n = 4 embryos). Embryos with Li+/HCy exposures and
control embryos are compared. Y-axis denotes average densitometric readings of gel
scans; X-axis shows treatments: grey bars, male embryos; red bars, female embryos.M. Han et al. / Reproducti
ayer is lost (Fig. 3I–K). After the early acute exposures, the ORO
ocalization and villi now appear unorganized and the ORO stain-
ng is seen in patches within the labyrinth. There are regions that
re almost completely devoid of ORO deposition in the labyrinth
Fig. 3J), while a neighboring region may  show intense staining
Fig. 3K). Lithium induced similar patch-like expression in a thin
aternal decidua layer (Fig. 3L). Folic acid supplementation with
oth exposures enabled more normal development and organiza-
ion of the labyrinth (Fig. 3M,  N) and maternal decidua (Fig. 3O, P).
lthough effects of Li+ were not completely prevented by folic acid
n the maternal decidua, the labyrinth development was  normal-
zed (3L).
In summary, placentas of embryos from the different litters and
xposed to Li+ or to HCys displayed the greatest decrease in ORO LD
ocalization and organization in the labyrinth and maternal decidua
ayers. Variability related to extent of areas that were completely
evoid of lipid droplets. In some placentas, the labyrinth displayed
ittle LD localization. Disorganization of the villi was generally
oted with exposure. Variability in the thickness of the maternal
ecidua was also noted and speciﬁcally with lithium exposure and
ith folic acid supplementation with lithium exposure. In all pla-
entas, the fetal side of the placenta did not show lipid localization.
.3. Changes in fatty acid oxidation genes with
ithium/homocysteine exposure
To deﬁne possible changes in lipid metabolism further, we
nalyzed two genes involved in fatty-acid oxidation, Acyl CoA dehy-
rogenase medium chain (Acadm) and Acyl CoA dehydrogenase long
hain (Acadl). Both genes appeared multiple times in the lipid-
elated GO categories deﬁned in the microarray analysis. These
enes were chosen because both genes were previously reported to
e associated with the heart. Acadm is linked with cardiomyocyte
ifferentiation and cold tolerance in mice [37]. Acadl is associated
ith sudden death occurring between 2 and 4 weeks of age after
irth, with evidence of cardiomyopathy, as well as reduced litter
izes [36]. Additionally, genetic disorders of fatty acid oxidation-
elated genes are known to exist in the human population and are
ecognized as important causes of morbidity and mortality [47].
.3.1. Acyl CoA dehydrogenase modulation
Gender of the embryos was not addressed in this initial part of
he study. We  used RT-PCR analysis of E15.5 cardiac tissue from
hree mouse embryos from three different litters after the E6.75
cute exposures. All of the experimentally exposed mouse embryos
isplayed abnormal cardiac function. Acadl and Acadm expression
as not greatly altered by Li or HCy exposure (Fig. 4A). Graphs of
ensitometric scan averages with standard deviations are shown to
he right (Fig. 4B–E). Data was normalized in each case to the inter-
al control -actin. Although not statistically signiﬁcant, a pattern
f up-regulation of Acadm gene expression seemingly occurred in
oth Li+- and HCy-exposure groups in comparison to control hearts
Fig. 4A). High FA supplementation maintained the expression close
o control levels. We  also analyzed gene expression a half a day
fter exposures in whole embryos at E7.5 and found that within
2 h, the changes in gene expression were observed (not shown).
e next analyzed whether the gender of the embryo may  relate
o our results. Because evidence exists that abundance of mRNA
ay  not correlate with that of protein [48], we also immunostained
15.5 embryonic male and female hearts, as well as placentas for
he Acadm gene product, MCAD protein (Figs. 5 and 7 )..3.1.1. MCAD protein expression in the heart. As seen in Fig. 5A–F
nd graphs 5G and 5H, in the male and female control hearts (Fig. 5A
nd D, respectively), a low level of MCAD protein is detectable
n the right (RV) and left (LV) ventricular walls, in the trabecu-Asterisks denote the p values for statistically signiﬁcant treatments in comparison
to  control same gender group. A p value <0.05 is considered signiﬁcant. * = p < 0.05;
**  = p < 0.005; *** = p < 0.0005; “n” equals numbers of embryos.
lae, and in the interventricular septum (IVS; arrows). After acute
HCy exposure, MCAD protein expression is highly elevated in the
male heart (Fig. 5B; see also graph in Fig. 5G) with a lower level
detectable in the female right and left ventricular walls and IVS
(Fig. 5E, arrows). Lithium exposure suppressed MCAD expression in
both male and female embryonic hearts (Fig. 5C and F), but a higher
level remained evident in the female (see graph in Fig. 5H). In sum-
mary, male embryonic hearts in response to HCy displayed the most
marked gender-associated change in MCAD protein expression. For
the experimentally exposed hearts, the percentages of the HRP sig-
nal in the quantiﬁed regions in relation to the whole area are given
for the delineated regions (the RV and LV myocardial walls and
the IVS). Thus, male and female embryonic hearts of embryos from
different litters responded differentially to Li+ and HCy exposures
with male hearts being more affected with exposure to elevated
HCy.
3.3.2. Modulation of acadm and MCAD expression in the placenta
and association with embryonic gender
After we  had sorted our microarray lipid-related GO categories
list by taking into account the sex of the embryos (Fig. 1A and B), it
appeared possible that gender differences may relate to the results
observed with ORO localization (Section 3.2.2) and with the ini-
tial RT-PCR analysis described above in Section 3.3.1. where the
gender of the embryos had not been speciﬁed. We then tested
for possible gender association by re-analyzing for Acadm gene
expression in relation to the E15.5 placenta and specifying gender
by RT-PCR genotyping (see Section 2, Section 2.6). We  focused on
lipid-related Acadm gene expression (Fig. 6A) and included Crt (cal-
reticulin, Fig. 6B) that is not directly involved in lipid metabolism
and determined whether a gender association would be noted. Crt is
involved in calcium homeostasis and implantation during placental
development [38].
RT-PCR analysis was  carried out on samples of total RNA
extracted from three male or three female placental tissues exposed
to Li+ or to HCy and were compared to three male and three female
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Fig. 7. Gender-associated changes in MCAD protein expression in placental tissue on E15.5 after HCy- and Li+ − E6.75 exposures. Arrows point to some regions of localization.
Male  control placental tissue (Fig. 7A, B) compared with female control (Fig. 7G, H) and after exposures to HCy (male Fig. 7C,D; female 7I, J) and to Li+ (male Fig. 7E,F; female
7K,L). For each gender left column displays low magniﬁcation of the placenta and right-hand column higher magniﬁcation of a delineated region of the labyrinth. For gender
comparisons in relation to HCy/Li+ exposures, the HRP signal was quantiﬁed in the maternal decidua and labyrinth and graph of data is shown in panel 7M.  Abbreviations:
MAT  De, Maternal Decidua; Syn Tr, Syncytiotrophoblasts; Lab, labyrinth. Magniﬁcation bar in A for low 4× magniﬁcation = 1 mm;  bar in B for 20× magniﬁcation = 100 m.
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ecidua. Inset in upper right in graph shows regions (green boxed-in areas) of place
ontrol placentas. All of these pregnant females received the health
aintenance diet of 3.3 mg/kg. All of the treated embryos had been
cutely exposed to either of the two factors and all displayed abnor-
al  echo patterns, including semilunar valve defects. The Acadm
xpression changes were compared to control placental tissues
f male and female embryos that displayed normal heart func-
ion. By taking into account gender and using ANOVA to analyze
ariance between the means of the groups and within groups, a
tatistical difference in expression at the 5% signiﬁcance level (P-
alue equaled 0.007) was seen in response to HCy. Placental tissue
f male embryos demonstrated a highly signiﬁcant difference in
cadm expression level in response to HCy exposure than female
mbryos (Fig. 6A). ANOVA analysis indicated that a signiﬁcant dif-lyzed. Solid grey bars depict male HCy-exposed tissue; solid red bars show female
ale Li+ −exposed tissue. LAB (on left), labyrinth tissue; MAT De (on right), maternal
at were analyzed.
ference in Acadm expression between genders was  not observed
in the response to lithium. The calreticulin (Crt) gene displayed
no gender association in its expression changes (Fig. 6B). Crt did
show, however, a statistical difference between the groups at the
5% signiﬁcance level, i.e. between control and experimental groups
with both genders responding similarly in response to HCy or to Li+
exposure.
MCAD protein expression in the placenta of male and female
control embryos was detected in multiple cell types of the pla-
centa, i.e., in the maternal decidua, syncytiotrophoblasts, and in
the villi of the labyrinth layers (Fig. 7A). Quantiﬁcation of HRP
signal in gender-related maternal decidua and in labyrinth lay-
ers is shown as percentage of HRP signal in delineated regions in
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elation to the whole speciﬁc areas analyzed. Our description of
evels of immunostaining is based on visual inspection of tissue
nd on software quantiﬁcation of duplicate sections and shown in
he graphs. The maternal decidua and labyrinth regions that were
uantiﬁed are boxed-in the inset on graph. As observed, only a
ow level of localization was seen in the control labyrinth (Fig. 7B
hown at higher magniﬁcation). Acute homocysteine early expo-
ure resulted in an up-regulation of MCAD in the male placenta
Fig. 7C shown at low 4× magniﬁcation, 7D in labyrinth shown
t higher 20× magniﬁcation) in contrast to the female placenta
here a low level of expression remained in the maternal decidua
7I, arrows) similar to control tissue, and a low level of expression
as noted in the labyrinth (7J). In response to Li+ exposure, the
ale placenta showed a down-regulation of MCAD in the maternal
ecidua (Fig. 7E) and little expression in the labyrinth (Fig. 7F); the
emale placenta also showed a down-regulation in the maternal
ecidua and displayed MCAD only in some areas in the labyrinth
ayer (arrows, Fig. 7L).
In summary, the highest change in MCAD protein expression
n the placenta was seen with male embryos in response to HCy
nd especially in the maternal decidua. A more modest increase in
he labyrinth is also observed. For both genders little change was
bserved in response to lithium.
. Discussion
The bioinformatic results of the microarray data using GO
ategories indicated that lipid metabolism in cardiac tissue was
rimarily altered with folic acid deﬁciency, the latter exempliﬁed
y early embryonic exposure to an elevation of HCy. In addition,
fter sorting the deﬁned GO categories list according to gender of
he embryos compared with the various treatments versus con-
rol embryos, a gender bias appeared to exist in the response
o the exposure with male embryos showing more lipid-related
rocesses affected than in the female. We  then validated the
icroarray-based results by demonstrating neutral lipid changes
ith exposures in the mouse heart and placenta using molecular
nd immunohistochemical techniques for changes in expression
f Acyl CoA dehydrogenase medium length chain (Acadm) gene and
ts protein MCAD. We  used Acadm as a biomarker because this
ene appeared multiple times in the lipid-related GO categories
hat were altered and it is the most common inherited disorder
f mitochondrial fatty acid -oxidation in humans. Expression of
cadm and MCAD displayed signiﬁcant changes in the placenta
nd in a gender-associated manner. We  discuss below how lipid
etabolism relates to cardiac and placental development and when
ysregulated can lead to pathophysiology and birth defects. We
hen discuss how changes in lipids also can alter Wnt  signaling that
s impacted more directly by the Li+ exposure. Lastly we describe
he intersection of lipid metabolism with the folic acid cycle.
.1. Lipid metabolism and disease
Bioenergetic maturation has been demonstrated to be an impor-
ant component of normal cardiomyocyte differentiation [49]. As
he developing heart increasingly relies on oxidative metabolism,
s the vasculature brings blood to the heart from the placenta, there
s a higher demand for energy to maintain continuous myocardial
ontractile activity. This energy requirement is primarily met  by
-oxidation of fatty acids in the mitochondria.Myocardial fatty acid metabolism in health and disease has been
eviewed in detail [50]. Recent evidence demonstrates that cyto-
lasmic lipases remove fatty acids from lipid droplets when cells
re starved and enable their transfer into mitochondria [51]. By E14icology 61 (2016) 82–96 93
mouse cardiac mitochondria are engaged in oxidative phosphory-
lation and fatty acid oxidation has been initiated [49].
Perturbation of placental development can lead to altered blood
ﬂow, smaller placentas, growth-restricted embryos, and to resorp-
tion of embryos that we also observed in our published studies
[3,11]. With the exception of the perfusing maternal blood, the
placenta is an embryonic tissue [52]. The placenta is composed of
trophoblast cells originating from the trophectoderm of the blasto-
cyst. Between embryonic days E4.5 and E7.5 in the mouse model,
the differentiation of different trophoblast lineages is ongoing [53].
Our exposures at E6.75 thus target this time-period of differen-
tiation. Subsequently, the extra-embryonic ectoderm expands and
forms the chorionic epithelium. Posteriorly the allantois forms from
the embryonic mesoderm and contacts the chorion at ∼E8.5. Feto-
placental blood vessels later grow in from the allantois to form
the fetal components of the vascular network of the placental
labyrinth. The labyrinth is where nutrient and gas exchange occurs
between the maternal and fetal circulations. Thus, perturbation of
trophoblast differentiation early during gestation has the potential
to alter subsequent placental organization and function.
As we demonstrated, Li+ and HCy exposures on E6.75 resulted
in disorganization of the villi and placental lipid changes in the
labyrinth and maternal decidual layers with large areas of these
regions devoid of neutral lipids, as well as displaying altered MCAD
expression. The control placenta shows a high level of lipid droplets
accumulated in cells with a normal nutrient supply. Possibly under
stress or with nutrient deprivation as with folic acid deﬁciency, the
placenta breaks down lipids to enable their transfer to the embryo
to maintain embryonic development and growth. Abnormal or
reduced fatty acid transfer during development would alter the
fatty acid composition of tissue lipids having short- and long-term
effects on cell structure and function, including cell signaling, and
can contribute subsequently to cardiac pathology. A mismatch in
the adult heart of fatty acid uptake/utilization, for example, leads to
an accumulation of lipids that can be toxic to cardiac myocytes lead-
ing to ventricular dysfunction and premature death. In the embryo
such a mismatch could result in suboptimal nutrition, oxygena-
tion, and alterations in the bioenergetics of the cells resulting in
decreased embryonic myocardial performance [3,16,54]. An impor-
tance of the placenta-heart axis for heart development was recently
reviewed [55,56].
As demonstrated in the results, the fatty acid oxidation gene
Acadm and its protein MCAD are modulated in the heart and pla-
centa with exposures to Li+ and HCy. Addressing gender differences
in gene expression in the heart and placenta, it was  observed that
with an elevation of HCy, a hallmark of nutrient deﬁciency, male
embryos showed a statistically signiﬁcant upregulation of Acadm
expression in comparison to females in which Acadm remained
close to control levels. The up-regulation may  be a response to
compensate for the nutrient deﬁciency. In the human population
genetic disorders of mitochondrial fatty acid-oxidation have been
recognized as important causes of morbidity and mortality, indicat-
ing the physiological signiﬁcance of fatty acids in general for cellular
energy production during periods of fasting and metabolic stress.
Human MCAD (ACADM) deﬁciency is the most frequently encoun-
tered disorder of the fatty acid oxidation pathway and overall is one
of the most recognizable inborn errors of metabolism [47]. Mouse
models have been generated for several of the enzymes involved
in fatty acid oxidation to analyze underlying causes for the dis-
ease characteristics. In general the mouse models of disorders of
mitochondrial fatty acid beta-oxidation have shown clinical signs
that include Reye-like syndrome and cardiomyopathy, and many
are cold intolerant [57]. Extrapolating our results to the ﬁrst month
of human pregnancy, modulation of fatty acid oxidation-related
enzymes such as Acadm by even mild folate deﬁciency that ele-
vates HCy levels and in the context of possible inborn errors of
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etabolism as for example, MTHFR allele heterozygosity [45,46], it
ould lead to more pronounced metabolic changes that manifest
n the offspring in late fetal stages or after birth and, as shown in
ur analysis, the severity may  have a gender relationship with male
mbryos being more affected. Our analysis may  provide a basis for
ertain adult cardiovascular diseases as well, based on the theory
f developmental origins of adult diseases [58,59].
.2. Dyslipidemia and birth defects
Based on ORO localization, neutral lipid droplet distribution was
ltered more in the placenta than in the heart. Despite the lack of
 mechanism speciﬁed in published studies, investigations have
ndicated that maternal dyslipidemia during human pregnancy
ncreases the risk of adverse pregnancy outcomes and congeni-
al heart defects [60,61]. A similar fetal metabolic effect exists in
ssociation with maternal diabetes [62].
.3. Lipids and Wnt  signaling
Besides energy storage, lipids serve in two other critical func-
ions by being structural components of membranes in lipid rafts
nd by lipid modiﬁcations of proteins regulating activity of cell sig-
aling factors. Lipid rafts are dynamic subdomains of the plasma
embrane that contain high concentrations of cholesterol and gly-
osphingolipids and have an important role in signal transduction
63,64]. Many cell signaling proteins localize into the lipid raft
omains of the plasma membrane. It was reported that choles-
erol levels, a major component of lipid rafts, could affect gene
xpression during skeletal muscle differentiation [65]. Besides that
f Wnt  signaling, cholesterol levels were reported also to modulate
ther growth factor signaling, e.g., EGF receptor-mediated, signal-
ng [66]. Lipid modiﬁcations are known to be necessary for active
nt  signaling [67,68] via two fatty acid modiﬁcations [69] impli-
ated in its secretion. After lipid modiﬁcation, Drosophila DWnt-1
artitions as a membrane-anchored protein and is sorted into lipid
aft detergent-insoluble microdomains of the plasma membrane
70]. Interestingly, an elevation of HCy was reported to signiﬁcantly
ncrease glomerular endothelial cell permeability by stimulating
ipid raft clustering to form redox signaling platforms [71]. Lipids
re thus critical in fetal development, not only as components of
embrane rafts and phospholipids, but also as ligands for receptors
nd transcription factors in gene regulation and in direct interac-
ions with proteins. Thus, Li+ that directly inhibits a critical step in
he Wnt  signaling pathway, GSK-3 activity [72], has the poten-
ial similarly to HCy, the latter through lipid changes related to
nt activity, to affect early cardiomyocyte and trophoblast differ-
ntiation and normal tissue formation downstream. It appears that
urther study of placental lipid changes with embryonic exposures
uring early pregnancy is an important area for future study in the
ffects on early development of the embryo and possibly for later
dult cardiovascular diseases [58,59,73].
.4. Intersection of lipid and folic acid metabolism
The intersection of lipid and folic acid metabolism suggest that
pigenetic regulation also is involved, as the folic acid cycle leads
o formation of S-adenosylmethionine (SAM) the primary methyl
onor for epigenetic modiﬁcations. It is apparent that the metabolic
r nutritional state of the organism directly inﬂuences epigenetic
odiﬁcations: Epigenetic modiﬁcations rely on substrates of inter-
ediary metabolism such as SAM, acetyl CoA, -ketoglutarate and
icotinamide adenine dinucleotide [74]. Because the same signal-
ng pathways active in cardiogenesis are involved in placentation,
eurogenesis, neural crest differentiation, and craniofacial devel-
pment, the development of multiple tissues can be affected duringicology 61 (2016) 82–96
gestation. As an example, children with congenital heart defects are
reported to be at increased risk of neural developmental disorders
or disabilities, or developmental delay [75]. The severity of defects
and those that predominate would reﬂect timing of exposures dur-
ing gestation, the level of the exposure, and as based on our present
results, possibly gender.
A commonality of pathways appears to be emerging that result
in cardiac birth defects induced by multiple factors that link folic
acid deﬁciency with altered lipid metabolism. These results may
relate also to the cardiac defects that are observed with dyslipi-
demia reported in association with pregnancies involving alcohol
abuse and result in Fetal Alcohol Spectrum of Defects (FASD). In
addition maternal diabetes and obesity are conditions that dysreg-
ulate lipid metabolism and are associated with congenital heart
defects [76–80]. The folic acid pathway and above-mentioned
disease states are interrelated also with Wnt  signaling. Wnt  sig-
naling is linked with adipocyte cell lineage and obesity [81], and
with folic acid metabolism in the mouse embryo [82], whereby
folic acid supplementation normalizes hyperactive WNT  activity.
These intersecting pathways are involved during early steps of cell
differentiation during placentation and embryogenesis in human
pregnancy, and when lipids are dysregulated, an association with
congenital heart defects in the offspring is observed [60].
A means of prevention of the birth defects induced by
dyslipidemia appears to exist by administering a higher folate sup-
plementation dose than currently formulated in prenatal vitamin
preparations and that the supplementation is initiated periconcep-
tionally. The necessary safe and effective dose for prevention of
cardiac defects in human pregnancy requires further clinical and
epidemiological studies [83], although we  used the 10.5 mg/kg dose
based on a published clinical study indicating this level had been
shown to be effective for prevention of birth defects in human preg-
nancy [28]. It was  stated recently in the Folate Expert Panel review
paper that there does not appear to be any toxic or abnormal effects
of circulating plasma folic acid [84].
Epidemiological, clinical and animal studies taken together
demonstrate that the intrauterine environment inﬂuences growth
and development of the embryo and fetus. Our results using the
mouse model, when extrapolated to human pregnancy, demon-
strate that in the ﬁrst month, speciﬁcally in the second and third
week post-conception, the human embryo is highly vulnerable to
exposure to environmental factors encountered by the pregnant
female. This critical window that we  targeted coincides with a
period of cell speciﬁcation and differentiation of cardiomyocytes
and trophoblast cells. Thus, an early intrauterine insult before a
woman recognizes her pregnancy already may have long-lasting
effects on tissue and organ function during pregnancy and postna-
tally.
5. Conclusions
Bioinformatic analysis of microarray data of embryonic heart
tissue, with and without high dose folic acid supplementation
during gestation, generated a list of common GO categories that
demonstrated that with Li+ and HCy embryonic exposures, a high
number of the affected categories related to lipid metabolism and
more alterations were observed in the male embryonic heart tran-
scriptome in relation to HCy exposure than in the female. Validation
of lipid changes was observed with Oil Red O-staining for neu-
tral lipid localization in embryonic mouse embryos demonstrating
that lipid droplets were altered with early Li+ and HCy exposures
in the fetal E15.5 four-chambered heart and in the placenta with
greater changes occurring in placental tissue. Modulation of the
fatty acid oxidation gene Acyl CoA Dehydrogenase Medium Length
Chain (Acadm) and its protein MCAD occurs in the heart and pla-
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enta with exposures. A gender bias to the gene modulation in
esponse to HCy exposure existed with placental tissue of male
mbryos demonstrating a highly signiﬁcant difference in Acadm
xpression as compared to female embryos and controls. A gender
ssociation for a higher level of MCAD protein expression was also
oted in the male embryonic heart in response to HCy. The gen-
er bias we suggest may  relate to the increased severity of heart
efects observed in male children, when compared to the female
n the human population. High dose folic acid dietary supplemen-
ation on morning of conception can prevent or reduce the above
hanges in neutral lipids and Acadm/MCAD expression in cardiac
nd placental tissues in both male and female embryos.
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